The Brigham and Dana-Farber Board Review in Oncology

Brigham and Women’s Hospital Board Review

Prepare for your medical oncology board exam with this in-depth CME program. Ideal for MOC.

If your primary viewing mode will be on a computer or tablet, we recommend the Online Video package. In addition to online access, you will receive a USB with MP4 files. Use the USB to watch offline or import into iTunes and other media players and then synch to your mobile device, laptop or desktop. Plus you save $130 including standard shipping charges vs the DVD package.

    Video
  • Audio MP3s
1295.0000
SKU: 361

Earn CME Credit with this Oncology Review

The Brigham and Dana-Farber Board Review in Oncology is a CME course designed to update knowledge and improve management strategies. Case-based presentations from a distinguished faculty of experts will help enhance patient care while you prep for the board exam by learning to:

  • Apply recommended oncology guidelines in clinical practice
  • Perform differential diagnosis of complex oncologic disorders
  • Identify and apply current therapeutic options for oncologic disorders
  • Evaluate and interpret up-to-date literature relevant to oncology
  • Illustrate knowledge of pathophysiology as it applies to management of oncology disorders
  • Apply knowledge gained to the ABIM certification/recertification oncology examinations

Discover New Guidelines

A clinically based update, this learn-at-your-own-pace CME board review in oncology provides a maximum of 31.75 AMA PRA Category 1 Credits and 31.75 MOC points. Available online or via USB, it provides access to unbiased, evidence-based content and case-based reviews so that you may expand your knowledge and incorporate the latest guidelines into your daily practice.

View our full list of Topics/Speakers, Faculty, Accreditation and Media Format information.

Quick Facts

Providers: Brigham and Women's Hospital and Oakstone

Course Director:
Wendy Y. Chen, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women's Hospital

Course Director, The Brigham Board Review Distance Learning Series:
Ajay K. Singh, MBBS, FRCP (UK), MBA
Senior Associate Dean for Postgraduate
Medical Education
Director, Master in Medical Sciences in
Clinical Investigation (MMSCI) Program
Associate Professor of Medicine
Harvard Medical School
Director, Office of Postgraduate
Medical Education
Department of Medicine
Brigham and Women's Hospital

Credits: Earn a maximum of 31.75 AMA PRA Category 1 Credits ™ and 31.75 MOC points

  • Molecular Genetics of Cancer - Nikhil Wagle, MD
  • Advances in Cancer Drug Development - Geoffrey I. Shapiro, MD, PhD
  • Infections in Cancer Patients - Lindsey Baden, MD
  • Symptom Management in Patients with Cancer - Andrew J. Lawton, MD
  • Communication: The Key to Excellence in End-of-Life Care - Rachelle E. Bernacki, MD
  • Biology of Hematopoietic Stem Cell Transplantation - Robert J. Soiffer, MD
  • Biology of Acute Leukemia and Myelodysplastic Syndromes - Benjamin L. Ebert, MD, PhD
  • Acute Leukemias - Daniel J. DeAngelo, MD, PhD
  • Myelodysplastic Syndrome - David P. Steensma, MD
  • Chronic Myelogenous Leukemia - Marlise R. Luskin, MD
  • Myeloproliferative Syndromes - Ann M. Mullally, MD
  • Multiple Myeloma - Kenneth C. Anderson, MD
  • Waldenstrom Macroglobulemia and Amyloidosis - Jorge Castillo, MD
  • Low Grade Lymphomas - Caron A. Jacobson, MD
  • High Grade Lymphomas - Eric D. Jacobsen, MD
  • Hodgkin's Lymphoma - Jennifer Crombie, MD
  • Diagnosis and Treatment of CLL and Related B Cell Malignancies - Matthew S. Davids, MD
  • Head and Neck Cancer - Robert I. Haddad, MD
  • Natural History, Screening, Surgery and Small Cell Lung Cancer - Bruce E. Johnson, MD
  • Non Small Cell Lung Cancer - Mark Awad, MD, PhD
  • Mesothelioma and Thymoma - David M. Jackman, MD
  • Thyroid Cancer - Jochen Lorch, MD
  • Carcinoid and Pancreatic Neuroendocrine Tumors - Jennifer Ang Chan, MD
  • Esophageal and Gastric Cancer - Peter C. Enzinger, MD
  • Pancreatic and Hepatobiliary Cancer - Brian M. Wolpin, MD
  • Anal Cancers - Robert J. Mayer, MD
  • Colorectal Cancers - Robert J. Mayer, MD
  • Gastrointestinal Cancer: Genetic Syndromes - Matthew Yurgelun, MD
  • Germ Cell Tumor: Maximizing Cure While Minimizing the Burden of Therapy - Mark M. Pomerantz, MD
  • Renal and Bladder Cancer - Guru P. Sonpavde, MBBS
  • Prostate Cancer Part I: Overview and Management of Localized Disease - Atish Choudhury, MD, PhD
  • Prostate Cancer Part II: Management of Disseminated Prostate Cancer - Atish Choudhury, MD, PhD
  • Melanoma - F. Stephen Hodi, MD
  • Sarcomas and Gastrointestinal Stromal Tumors (GIST) - George D. Demetri, MD
  • Ovarian Cancer - Ursula A. Matulonis, MD
  • Cervical and Endometrial Cancer - Panagiotis A. Konstantinopoulos, MD, PhD
  • Neuro-oncology - David A. Reardon, MD
  • Breast Cancer: Risk Factors, Genetics, Screening, and Prevention - Judy E. Garber, MD, MPH
  • Multimodality Therapy for Early Stage Breast Cancer: Part 1 - Surgery and Radiation - Harold J. Burstein, MD, PhD
  • Multimodality Therapy for Early Stage Breast Cancer: Part 2 - Systemic Therapy - Harold J. Burstein, MD, PhD
  • Management of Metastatic Breast Cancer - Erica Mayer, MD, MPH
  • Breast Cancer Survivorship - Ann H. Partridge, MD, MPH

Course Director

Wendy Y. Chen, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Course Director, The Brigham Board Review Distance Learning Series

Ajay K. Singh, MBBS, FRCP(UK), MBA

  • Senior Associate Dean for Postgraduate Medical Education
  • Director, Master in Medical Sciences in
  • Clinical Investigation (MMSCI) Program
  • Associate Professor of Medicine
  • Harvard Medical School
  • Director, Office of Postgraduate Medical Education
  • Department of Medicine
  • Brigham and Women's Hospital

Faculty

Kenneth C. Anderson, MD

  • Kraft Family Professor of Medicine
  • Harvard Medical School
  • Dana Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Mark Awad, MD, PhD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Lindsey Baden, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Division of Infectious Diseases
  • Department of Medicine
  • Brigham and Women’s Hospital

Rachelle E. Bernacki, MD, MS, FAAHPM, AGSF

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Harold J. Burstein, MD, PhD

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Jorge J. Castillo, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Jennifer Ang Chan, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Atish D. Choudhury, MD, PhD

  • Instructor In Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Jennifer L. Crombie, MD

  • Instructor in Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Matthew S. Davids, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Daniel J. DeAngelo, MD, PhD

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

George D. Demetri, MD

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Benjamin L. Ebert, MD, PhD

  • George P. Canellos, MD, and Jean S. Canellos Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Peter C. Enzinger, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Judy E. Garber, MD, MPH

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Robert I. Haddad, MD

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

F. Stephen Hodi, MD

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

David M. Jackman, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Eric D. Jacobsen, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Caron A. Jacobson, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

 

Bruce E. Johnson, MD

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Panagiotis A. Konstantinopoulos, MD, PhD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Andrew J. Lawton, MD

  • Instructor in Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Jochen Lorch, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Marlise R. Luskin, MD

  • Instructor in Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Ursula A. Matulonis, MD

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Erica Mayer, MD, MPH

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Robert J. Mayer, MD

  • Stephen B. Kay Family
  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Ann M. Mullally, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Ann H. Partridge, MD, MPH

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Mark M. Pomerantz, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

David A. Reardon, MD

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Geoffrey I. Shapiro, MD, PhD

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Robert J. Soiffer, MD

  • Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Guru P. Sonpavde, MBBS

  • Member of the Faculty of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

David P. Steensma, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Nikhil Wagle, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Brian M. Wolpin, MD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Matthew Yurgelun, MD

  • Assistant Professor of Medicine
  • Harvard Medical School
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Brigham and Women’s Hospital

Accreditation

Oakstone Publishing is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

Oakstone Publishing designates this enduring material for a maximum of 31.75 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 31.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Date of Original Release: April 15, 2020
Termination Date: April 15, 2023

Learning Objectives

At the conclusion of this activity, the participant will be able to:

  • Apply current/recommended Oncology guidelines in clinical practice
  • Perform differential diagnosis of complex clinical presentations related to Oncologic disorders
  • Identify/apply current therapeutic options for specific Oncologic disorders
  • Review and interpret up-to-date literature relevant to clinical practice in Oncology
  • Demonstrate knowledge of pathophysiology as it applies to management of Oncology disorders
  • Apply knowledge gained to the ABIM Certification/Recertification Medical Oncology examinations

Intended Audience

The activity was planned for fellows/trainees, practicing Oncology specialists (MDs), and other professional affiliates (internists with an interest in Oncology) who are preparing to take ABIM Board Review or Recertification Examinations, or who seek CME activities to improve patient care in the areas of Oncology Medicine.